Loading financials from SEC filings…
Household & personal products · Consumer Defensive · Fiscal year ends Dec 31
Interparfums reported revenue of $1.5B in the fiscal year ended Dec 2025, up 2.5% from the year before. Operating income was $270M, an operating margin of 18.2%, and net income was $168M. Operating cash flow of $215M less capital expenditure of $24M left free cash flow of $190M.
Ranks among the 12 household & personal products companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 880 | 1,087 | 1,318 | 1,452 | 1,489 |
| Cost of revenue | 323 | 392 | 479 | 525 | 541 |
| Gross profit | 557 | 694 | 839 | 927 | 947 |
| Selling, general & admin | 406 | 492 | 588 | 649 | 677 |
| Operating income | 148 | 194 | 251 | 275 | 270 |
| Interest expense | 2.8 | 3.6 | 11.3 | 7.8 | 7.2 |
| Pre-tax income | 151 | 194 | 250 | 268 | 271 |
| Income tax | 41.0 | 43.2 | 61.8 | 65.0 | 63.2 |
| Net income | 87.4 | 121 | 153 | 164 | 168 |
| Diluted EPS | 2.75 | 3.78 | 4.75 | 5.12 | 5.24 |
| Diluted shares | 31.8 | 32.0 | 32.1 | 32.1 | 32.1 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 159,613 | 105 | – | – | – |
| Receivables | 159 | 198 | 247 | 275 | 321 |
| Inventory | 199 | 290 | 372 | 372 | 351 |
| Current assets | 710 | 788 | 839 | 926 | 1,027 |
| Net PP&E | 149 | 167 | 169 | 154 | 185 |
| Total assets | 1,145 | 1,309 | 1,369 | 1,411 | 1,585 |
| Payables | 82.0 | 88.4 | 97.4 | 91.0 | 77.2 |
| Current liabilities | 245 | 345 | 325 | 332 | 344 |
| Short-term debt | 15.9 | 28.5 | 29.6 | 41.6 | 54.8 |
| Long-term debt | 133 | 151 | 128 | 116 | 121 |
| Total liabilities | 407 | 520 | 477 | 469 | 481 |
| Shareholders' equity | 572 | 617 | 699 | 745 | 881 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 120 | 73.0 | 106 | 188 | 215 |
| Capital expenditure | 141 | 33.8 | 6.5 | 4.7 | 24.4 |
| Free cash flow | −21.7 | 39.3 | 99.3 | 183 | 190 |
| Depreciation & amortisation | 12.7 | 22.5 | 17.3 | 28.4 | 25.3 |
| Stock-based compensation | 2.9 | 3.1 | 2.5 | 2.4 | 1.6 |
| Dividends paid | 31.7 | 63.7 | 80.0 | 96.0 | 103 |
| Dividend per share | 1.00 | 2.00 | 2.50 | 3.00 | 3.20 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 23.6% | 21.3% | 10.2% | 2.5% |
| Operating income growth (YoY) | – | 31.2% | 29.4% | 9.3% | −1.6% |
| EPS growth (YoY) | – | 37.5% | 25.7% | 7.8% | 2.3% |
| Gross margin | 63.3% | 63.9% | 63.7% | 63.9% | 63.6% |
| Operating margin | 16.8% | 17.9% | 19.1% | 18.9% | 18.2% |
| Net margin | 9.9% | 11.1% | 11.6% | 11.3% | 11.3% |
| Return on equityBlank when equity is negative | 15.3% | 19.6% | 21.8% | 22.1% | 19.1% |
| ROCEEBIT ÷ (assets − current liabilities) | 16.4% | 20.2% | 24.1% | 25.5% | 21.8% |
| Free cash flow margin | −2.5% | 3.6% | 7.5% | 12.6% | 12.8% |
| Cash conversion (CFO ÷ net income) | 1.37x | 0.60x | 0.69x | 1.14x | 1.28x |
| Receivable days | 66 | 66 | 68 | 69 | 79 |
| Inventory days | 225 | 270 | 284 | 259 | 237 |
| Payable days | 93 | 82 | 74 | 63 | 52 |
| Interest cover | 52.4x | 54.0x | 22.3x | 35.1x | 37.3x |
| Debt ÷ equity | 0.26x | 0.29x | 0.23x | 0.21x | 0.20x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | −159,464 | 75.3 | – | – | – |
| Current ratio | 2.90x | 2.29x | 2.58x | 2.79x | 2.99x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.